Faridoxorubicin

Overview

Faridoxorubicin (AVA-6000) is a prodrug targeting fibroblast activation protein α ( FAPα ). Faridoxorubicin releases active doxorubicin through FAPα-mediated cleavage, enhancing intratumoral drug exposure and reducing cardiac toxicity. Faridoxorubicin is promising for research of solid tumors (e.g., colorectal cancer liver metastasis).

Application

Products | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > FAP

Product Information

• Catalog No.: HY-177083
• CAS No.: 1841402-73-0
• Molecular Formula: C41H44N4O14
• Molecular Weight: 816.81
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source